임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

18건 표시

3상모집 중· Non-small Cell Lung Cancer
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT07513376
2상모집 중· Lyme Disease
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
리드: 모더나
상세 →NCT07561294
3상모집 중· Influenza
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
리드: 모더나
상세 →NCT07496450
1상모집 중· Epstein-Barr Virus
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age
리드: 모더나
상세 →NCT07478952
2상모집 중· Squamous Non-small Cell Lung Cancer
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT07221474
1/2상모집 중· Relapsed or Refractory Multiple Myeloma
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
리드: 모더나
상세 →NCT07116616
1상모집 중· Cutaneous Melanoma
ACTengine® IMA203 Combined With mRNA-4203
협력: 모더나
상세 →NCT06946225
2상모집 중· Multiple Sclerosis
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
리드: 모더나
상세 →NCT06735248
2상모집 중· Urinary Bladder Neoplasms
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT06833073
3상모집 중· Carcinoma, Non-Small-Cell Lung
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT06623422
4상모집 중· SARS-CoV-2
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
리드: 모더나
상세 →NCT06585241
3상모집 중· Non-small Cell Lung Cancer
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
리드: 머크(MSD) · 협력: 모더나
상세 →NCT06077760
단계 미표기모집 중· Cytomegalovirus Infections
Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
협력: 모더나
상세 →NCT06522880
단계 미표기모집 중· Propionic Acidemia
A Retrospective Study to Characterize Participants With Propionic Acidemia
리드: 모더나
상세 →NCT05769621
1/2상모집 중· Advanced Solid Tumors
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
리드: 모더나
상세 →NCT05533697
1/2상모집 중· Methylmalonic Acidemia
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
리드: 모더나
상세 →NCT05295433
1/2상모집 중· Propionic Acidemia
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
리드: 모더나
상세 →NCT05130437
1/2상모집 중· Propionic Acidemia
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
리드: 모더나
상세 →NCT04159103

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.